NewLimit (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- May 16, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $130,000,000
Company Info
- Company Description
- NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
- Market
- Age-related diseases
- Location
- South San Francisco, California, USA
- Coinvestors
- Dimension Capital, Elad Gil, Founders Fund, Fred Ehrsam, Garry Tan, Human Capital, Joe Lonsdale, Josh Kushner, Khosla Ventures, Kleiner Perkins Caufield and Byers